Drug Type Small molecule drug |
Synonyms Ulvenzepine, DF 594, DF-594 |
Target |
Action antagonists |
Mechanism M3 receptor antagonists(Muscarinic acetylcholine receptor M3 antagonists), mAChRs antagonists(Muscarinic acetylcholine receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H21ClN4O2 |
InChIKeyOSLNWPFLHSLBPY-UHFFFAOYSA-N |
CAS Registry121798-89-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 2 | Italy | - | |
Asthma | Phase 2 | United Kingdom | - | - |
Asthma | Phase 2 | - | - | |
Bronchitis | Phase 2 | Italy | - | |
Bronchitis | Phase 2 | United Kingdom | - | - |
Bronchitis | Phase 2 | - | - |